ANIX
Anixa Biosciences Inc (ANIX
NASDAQ · Healthcare · Biotechnology · US
$2.61
−2.25%Next report
Analyst consensus
- Next report date
- Jan 11, 2027
- EPS estimate
- -$0.08
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 9, 2026
- EPS actual
- -$0.08
- EPS estimate
- -$0.08
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +18.1%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $6.00
- PT range
- $6.00 – $6.00
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 9, 2026 | -$0.08 | -$0.08 | Beat 2.20% | — |
| Jun 10, 2026 | -$0.10 | -$0.07 | Beat 30.00% | — |
| Mar 9, 2026 | -$0.09 | -$0.08 | Beat 10.16% | — |
| Sep 10, 2025 | -$0.10 | -$0.07 | Beat 30.00% | — |
| May 28, 2025 | -$0.10 | -$0.09 | Beat 10.00% | — |
| Mar 11, 2025 | -$0.10 | -$0.10 | In line | — |
| Sep 6, 2024 | -$0.11 | -$0.10 | Beat 9.09% | — |
| Jun 4, 2024 | -$0.11 | -$0.10 | Beat 9.09% | — |
| Mar 12, 2024 | -$0.09 | -$0.10 | Miss -11.11% | — |
| Sep 6, 2023 | -$0.09 | -$0.08 | Beat 11.11% | — |
| Jun 14, 2023 | -$0.11 | -$0.07 | Beat 36.36% | $210.0K |
| Mar 16, 2023 | -$0.16 | -$0.08 | Beat 50.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jan 11, 2027